29.08.2013 • Newsbee diseasebee populationCCD

Syngenta Contests EU Move to Restrict Thiamethoxam

Swiss agrochemicals giant Syngenta has filed a legal challenge to a decision by the EU Commission (EC) to restrict application of thiomethoxam, one of the active ingredients in pesticides and seed treatments used on bee-attractive crops. The group said the EC's decision was "based on a flawed process, an inaccurate and incomplete assessment by the European Food Safety Authority (EFSA) and without the full support of EU Member States."

At the end of April, following approval by a simple majority of 15 member states, the Commission pressed ahead with plans to restrict use of a number of neonicotinoid-related products for two years - from December 2013 - due to fears they may be at least partly to blame for the decline in bee populations known as Colony Collapse Disorder (CCD). The restrictions will apply to the use of neonicotinoids on all crops except winter cereals and plants not attractive to bees, such as sugar beet.

The European action, made possible by rules that allowed the Commission to proceed without a weighted majority vote, is the world's first continent-wide suspension imposed on widely used insecticides. In the period leading up to the decision, Syngenta and other manufacturers of neonicitonid active ingredients such as Bayer, had proposed alternative strategies.

 "We would prefer not to take legal action but have no other choice given our firm belief that the Commission wrongly linked thiamethoxam to the decline in bee health. In suspending the product, it breached EU pesticide legislation and incorrectly applied the precautionary principle," said John Atkins, Syngenta's chief operating officer.

Since the EU suspension of thiamethoxam was announced, Atkins said farmers and their organizations "have expressed great concern that an extremely effective, low dose product will not be available to them and will have to be replaced by much less sustainable alternatives."

 

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.